A detailed history of Ubs Asset Management Americas Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 17,756,021 shares of MRK stock, worth $1.71 Billion. This represents 0.53% of its overall portfolio holdings.

Number of Shares
17,756,021
Previous 17,446,365 1.77%
Holding current value
$1.71 Billion
Previous $2.16 Billion 6.64%
% of portfolio
0.53%
Previous 0.63%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $34.4 Million - $39.9 Million
309,656 Added 1.77%
17,756,021 $2.02 Billion
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $606 Million - $651 Million
4,898,995 Added 39.04%
17,446,365 $2.16 Billion
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $13.9 Million - $16.2 Million
-122,597 Reduced 0.97%
12,547,370 $1.66 Billion
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $1.79 Million - $1.95 Million
17,903 Added 0.14%
12,669,967 $1.38 Billion
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $76.8 Million - $85.3 Million
746,357 Added 6.27%
12,652,064 $1.3 Billion
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $33.1 Million - $37 Million
-322,004 Reduced 2.63%
11,905,707 $1.27 Billion
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $5.68 Million - $7.28 Million
64,902 Added 0.53%
12,227,711 $1.36 Billion
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $22.4 Million - $25.2 Million
265,432 Added 2.23%
12,162,809 $1.05 Billion
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $1.35 Million - $1.53 Million
16,184 Added 0.14%
11,897,377 $1.08 Billion
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $19 Million - $21.3 Million
-258,147 Reduced 2.13%
11,881,193 $975 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $40.4 Million - $50.6 Million
-559,316 Reduced 4.4%
12,139,340 $930 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $76.7 Million - $84.3 Million
1,069,797 Added 9.2%
12,698,656 $954 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $44.5 Million - $49.2 Million
-632,801 Reduced 5.16%
11,628,859 $904 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $7.97 Million - $9.39 Million
115,757 Added 0.95%
12,261,660 $902 Million
Q4 2020

Mar 01, 2021

SELL
$71.77 - $79.65 $24.8 Million - $27.5 Million
-345,745 Reduced 2.77%
12,145,903 $948 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $22.5 Million - $25.5 Million
308,003 Added 2.53%
12,491,648 $989 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $133 Million - $151 Million
-1,884,504 Reduced 13.4%
12,183,645 $899 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $29.6 Million - $41.1 Million
467,891 Added 3.44%
14,068,149 $1.03 Billion
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $14.8 Million - $16.8 Million
191,393 Added 1.43%
13,600,258 $1.18 Billion
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $133 Million - $145 Million
1,747,453 Added 14.98%
13,408,865 $1.08 Billion
Q2 2019

Aug 15, 2019

BUY
$69.84 - $81.59 $138 Million - $161 Million
1,972,587 Added 20.36%
11,661,412 $0
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $31.3 Million - $35.7 Million
450,145 Added 4.87%
9,688,825 $0
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $12.2 Million - $14.2 Million
187,361 Added 2.07%
9,238,680 $674 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $5.26 Million - $6.19 Million
-91,245 Reduced 1.0%
9,051,319 $0
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $55,353 - $65,035
1,089 Added 0.01%
9,142,564 $0
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $48.3 Million - $56.1 Million
947,112 Added 11.56%
9,141,475 $0
Q4 2017

Feb 09, 2018

SELL
$51.62 - $61.64 $41.4 Million - $49.4 Million
-802,053 Reduced 8.92%
8,194,363 $0
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $528 Million - $568 Million
8,996,416
8,996,416 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.